Who owns SENSEI BIOTHERAPEUTICS INC?
- Ticker: SNSE
- CUSIP Number: 81728a108
Tip: Access positions for across all investors
Analyze quarterly positions in Sensei Biotherapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Sensei Biotherapeutics stock
Who bought or sold SENSEI BIOTHERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Ikarian Capital | 650k | $389k | 0% | Sep 2024 |
|
| Vanguard Group | 619k | $384k | 8% | Jun 2024 |
|
| Renaissance Technologies | 216k | $129k | -4% | Sep 2024 |
|
| Geode Capital Management | 163k | $98k | 0% | Sep 2024 |
|
| Susquehanna International | 90k | $54k | 100% | Sep 2024 |
|
| Bridgeway Capital Management | 78k | $48k | -31% | Jun 2024 |
|
| Citadel Advisors | 66k | $40k | 330% | Sep 2024 |
|
| National Bank Of Canada /fi/ | 46k | $27k | 356% | Sep 2024 |
|
| Northern Trust | 26k | $16k | 0% | Sep 2024 |
|
| State Street Corporation | 26k | $16k | 0% | Jun 2024 |
|
| Raymond James & Associates | 20k | $12k | 43% | Sep 2024 |
|
| Two Sigma Securities | 19k | $12k | 100% | Jun 2024 |
|
| Morgan Stanley | 12k | $7.6k | 0% | Jun 2024 |
|
| Deuterium Capital Management | 11k | $6.8k | 0% | Jun 2024 |
|
| BlackRock | 7.8k | $4.8k | -77% | Jun 2024 |
|
| Tower Research Capital | 7.1k | $4.4k | 6% | Jun 2024 |
|
| Jpmorgan Chase & Co | 707.00 | $422.291100 | -5% | Sep 2024 |
|
| Bank of America Corporation | 258.00 | $153.664800 | 86% | Sep 2024 |
|
| Qube Research & Technologies | 4.00 | $2.000000 | 0% | Jun 2024 |
|
Who sold out of Sensei Biotherapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Two Sigma Advisers | Mar 2024 | 19k | $20k |
| Leo Wealth | Jun 2024 | 15k | $9.2k |
| XTX Topco | Jun 2024 | 14k | $8.7k |
| Two Sigma Investments | Mar 2024 | 10k | $11k |
| Banque Cantonale Vaudoise | Jun 2024 | 3.9k | $2.0k |
| Royal Bank of Canada | Jun 2024 | 247.00 | $0 |